Volume 66, Issue 6, Pages (December 2004)

Slides:



Advertisements
Similar presentations
Volume 68, Pages S24-S28 (July 2005)
Advertisements

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Treatment of experimental renal osteodystrophy with pamidronate
Volume 60, Issue 6, Pages (December 2001)
Plasma sodium and hypertension
Treatment of experimental renal osteodystrophy with pamidronate
Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Viper venom for diabetic nephropathy
Volume 80, Issue 6, Pages (September 2011)
FGF23 or PTH: which comes first in CKD ?
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Volume 68, Issue 4, Pages (October 2005)
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Volume 59, Issue 1, Pages (January 2001)
Membranous nephropathy: When and how to treat
Viper venom for diabetic nephropathy
FGF23–parathyroid interaction: implications in chronic kidney disease
Progression of renal failure and hypertensive nephrosclerosis
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
Volume 60, Issue 6, Pages (December 2001)
Volume 63, Issue 3, Pages (March 2003)
Volume 70, Issue 11, Pages (December 2006)
Volume 79, Pages S20-S23 (April 2011)
Use of vitamin D in chronic kidney disease patients
Volume 87, Issue 2, Pages (February 2015)
Volume 72, Issue 8, Pages (October 2007)
Volume 80, Issue 5, Pages (September 2011)
Volume 69, Issue 3, Pages (February 2006)
Volume 68, Issue 6, Pages (December 2005)
Volume 70, Issue 12, Pages (December 2006)
Volume 86, Issue 3, Pages (September 2014)
Volume 68, Pages S24-S28 (July 2005)
Volume 70, Issue 11, Pages (December 2006)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 66, Issue 6, Pages (December 2004)
The future of renoprotection: Frustration and promises
Volume 74, Issue 8, Pages (October 2008)
Volume 87, Issue 3, Pages (March 2015)
Angiotensin II production and distribution in the kidney – II
Volume 67, Issue 4, Pages (April 2005)
Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats  Quaisar Ali,
Volume 85, Issue 6, Pages (June 2014)
Volume 63, Issue 1, Pages (January 2003)
Volume 78, Issue 4, Pages (August 2010)
Fibroblast growth factor 23: the making of a hormone
Phosphate and the parathyroid
The course of the remnant kidney model in mice
Phosphate binders on iron basis: A new perspective?
Clinical benefits of slowing the progression of renal failure
Nosratola D. Vaziri, M.D., Kaihui Liang  Kidney International 
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 68, Issue 5, Pages (November 2005)
A functional immature model of chronic partial ureteral obstruction1
Volume 61, Issue 3, Pages (March 2002)
Increased parathyroid expression of klotho in uremic rats
Volume 68, Pages S98-S102 (December 2005)
Volume 64, Issue 4, Pages (October 2003)
Recent developments in the management of secondary hyperparathyroidism
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
T cells and T-cell receptors in acute renal failure
Volume 58, Issue 6, Pages (December 2000)
Increased fetuin-A levels following treatment with a vitamin D analog
Volume 60, Issue 5, Pages (November 2001)
Volume 55, Issue 3, Pages (March 1999)
Volume 61, Issue 4, Pages (April 2002)
Marta Christov, Harald Jüppner  Kidney International 
Proteinuria and hypertension with tyrosine kinase inhibitors
Volume 56, Issue 6, Pages (December 1999)
Presentation transcript:

Volume 66, Issue 6, Pages 2155-2166 (December 2004) High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure  Ilkka Pörsti, Meng Fan, Peeter Kööbi, Pasi Jolma, Jarkko Kalliovalkama, Tuija I. Vehmas, Heikki Helin, Harry Holthöfer, Eero Mervaala, Tuulikki Nyman, Ilkka Tikkanen  Kidney International  Volume 66, Issue 6, Pages 2155-2166 (December 2004) DOI: 10.1111/j.1523-1755.2004.66006.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 The 12-week study. Renal tissue angiotensin-converting enzyme (ACE) and angiotensin II type 1 (AT1) receptor density (related to the mean value of the sham group), and urinary albumin excretion. Representative original tracings (intensity of red coloring reflects active binding to tissue ACE (A), and bar graphs (B) (N = 9 to 10) of ACE determined by quantitative in vitro autoradiography; ACE protein determined by Western blotting (C) (N = 9 to 10 except for N = 5 in the calcium-sham group); urinary albumin excretion (D) (N = 9 to 10); AT1 receptors in the kidney cortex (E) and medulla (F) determined by quantitative in vitro autoradiography. Mean ± SEM. *P < 0.05 versus sham; †P < 0.05 versus NTX. Kidney International 2004 66, 2155-2166DOI: (10.1111/j.1523-1755.2004.66006.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 The 12-week study. Scatter plots of plasma parathyroid hormone (PTH) (A), phosphate (B), ionized calcium (C), and urinary calcium excretion (D) proportionate to renal tissue angiotensin-converting enzyme (ACE) content in the NTX and calcium-NTX groups; quantities of ACE were related to the mean value of the sham group (N = 9 to 10 in each group). Kidney International 2004 66, 2155-2166DOI: (10.1111/j.1523-1755.2004.66006.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 The 27-week study. Cumulative survival (A), immunohistochemistry of kidney tissue connective tissue growth factor (CTGF) (B), renal tissue angiotensin-converting enzyme (ACE) determined by autoradiography (C) and Western blotting (D), and angiotensin II type 1 (AT1) receptor density in renal cortex (E) and medulla (F); quantities of ACE and AT1 receptors were related to the mean value of the sham group. Mean ± SEM (N = 7 to 11 in each group). *P < 0.05 versus sham; †P < 0.05 versus NTX. Kidney International 2004 66, 2155-2166DOI: (10.1111/j.1523-1755.2004.66006.x) Copyright © 2004 International Society of Nephrology Terms and Conditions